Poland· PL-100448772
Tobrex
A tobramycin product containing tobramycinum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tobramycin is registered in 10 of 19 countries.
Countries holding a registration under ATC S01AA12 (tobramycin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Tobramycin · ATC S01AA12
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Tobramycinum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01AA12
- ATC class
- Tobramycin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991449551
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tobramycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTobramycinProficient Rx LP
- FinlandTobrexAlcon Couvreur N.V.
- BelgiumTobravisc 3 mg/mlNovartis Pharma
- CzechiaTOBREXNovartis s.r.o., Praha
- NetherlandsTobrabact, oogdruppels, oplossing 3 mg/mlMedicom Healthcare Ireland Limited
- United KingdomBramitob 300mg/4ml nebuliser solution 4ml ampoulesChiesi Ltd
- SpainBRAMITOB 300 mg/4 ml SOLUCION PARA INHALACION POR NEBULIZADORChiesi España S.A.U.
- GermanyBramitobChiesi Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Bramitob, Tobi
- Belgium · Obracin, Tobi
- Bulgaria · Tобрекс, Тобрамизил
- Cyprus · Bramitob, Ikobel
- Czechia · Bramitob, Tobramycin Vioser
- Germany · Bramitob, Gernebcin
- Denmark · Nebcina, Tobi
- Estonia · Tobramycin Via Pharma, Tobrex
- Spain · Bramitob, Tobrabact
- Finland · Tobi
- France · Nebcine, Tobi
- United Kingdom (Northern Ireland) · Bramitob, Munuza
- Greece · Bramitob, Eyetobrin
- Croatia · Bramitob, Tobrex
- Hungary · Bramitob, Brulamycin
- Ireland · Bramitob, Tobi
- Iceland · Tobi Podhaler, Vantobra
- Italy · Bramicil, Bramitob
- Liechtenstein · Tobi Podhaler, Vantobra
- Lithuania · Bramitob, Tobramycin Via Pharma
- Luxembourg · Obracin, Tobi
- Latvia · Bramitob, Tobramycin Via Pharma
- Malta · Tobi, Tobrex
- Netherlands · Bramitob, Obracin
- Norway · Bramitob, Nebcina
- Portugal · Bramitob, Tobi
- Romania · Tobi, Tobramicină Sun
- Sweden · Bramitob, Nebcina
- Slovenia · Tobrex
- Slovakia · Bramitob, Tobrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2962fe6-3c29-4e64-8822-be5a538522a5 GET /v1/drugs/b2962fe6-3c29-4e64-8822-be5a538522a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "3 mg/ml",
"packaging": "05909991449551 ¦ Rp ¦ 139467\n1 butelka 5 ml",
"substance": "Tobramycinum 3 mg/ml",
"common_name": "Tobramycinum",
"pl_product_id": "100448772",
"pozwolenie_nr": "78/21",
"auth_procedure": "IR",
"authorisation_validity": "2031-03-04"
}See everything about tobramycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.